Rockefeller Capital Management L.P. Acquires 69,441 Shares of Acadia Healthcare Company, Inc. $ACHC

Rockefeller Capital Management L.P. boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7,490.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 70,368 shares of the company’s stock after acquiring an additional 69,441 shares during the period. Rockefeller Capital Management L.P. owned 0.08% of Acadia Healthcare worth $999,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in the stock. Goldman Sachs Group Inc. grew its stake in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. acquired a new position in Acadia Healthcare in the fourth quarter valued at about $47,960,000. Wellington Management Group LLP grew its position in shares of Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after buying an additional 2,350,760 shares during the period. Invenomic Capital Management LP increased its stake in shares of Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after acquiring an additional 1,375,647 shares during the last quarter. Finally, Deerfield Management Company L.P. acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at approximately $29,440,000.

Analysts Set New Price Targets

ACHC has been the subject of a number of analyst reports. Cantor Fitzgerald boosted their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a report on Friday, May 1st. KeyCorp reissued an “overweight” rating and set a $30.00 price target on shares of Acadia Healthcare in a research report on Wednesday, May 27th. Guggenheim boosted their price target on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th. Finally, Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $26.85.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $31.91 on Friday. The firm has a market cap of $2.93 billion, a P/E ratio of -2.61, a PEG ratio of 10.42 and a beta of 0.64. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $32.82. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The firm’s 50 day moving average price is $25.62 and its two-hundred day moving average price is $21.16.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same quarter in the prior year, the firm earned $0.40 earnings per share. The firm’s revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.